JAT has agreed (subject to shareholder approval) to purchase a controlling 51% interest in Sunnya Pty. Ltd (Sunnya), an Australian exporter with a portfolio of milk powders and health products currently selling in China.
“The acquisition of Sunnya will broaden our in-house product range substantially,” JAT Executive Director Wilton Yao said. “We see great potential, combining Sunnya products and JAT distribution capacity. These products are already selling into China and we will boost their sales through our online platforms and offline distribution channels.”
Sunnya has developed branded product ranges for health, maternal and baby markets in China.
Key product ranges include:
NEURIO – Lactoferrin Milk Powder, DHA Algae Oil Softgel, and Probiotics Liquid, primarily selling in maternal and baby stores and local supermarkets.
RAICARE Goat Premium Infant Formula – An application for CFDA approval to continue sales under the new regulatory regime has been lodged.
“The directors of Sunnya also bring extensive expertise in the research and development of new dairy products, infant formulas, and other health products,” Mr. Yao said. “We are looking forward to working closely with Sunnya to develop more products to offer the market in the near future.”
The Directors of JAT and Sunnya are confident that, working together the businesses will achieve significantly higher growth rates and profitability than the businesses would separately.
For more information: refer to JAT’s ASX announcement: Acquisition of Sunnya Pty Limited.